Literature DB >> 9517611

Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?

J Rello1, D Mariscal, F March, P Jubert, F Sanchez, J Valles, P Coll.   

Abstract

A prospective observational study was performed to determine whether recurrent episodes of pneumonia caused by Pseudomonas aeruginosa in ventilated patients were due to a relapse of the previous clone or to reinfection with a new one. Diagnosis was based on quantitative cultures of secretions obtained by bronchoscopy. Comparison of strains was made by chromosomal fingerprinting based on pulsed field gel electrophoresis (PFGE). Thirty-three (89.1%) of 37 patients survived the initial week after pneumonia diagnosis; six survivors (18.1%) had multiple episodes caused by the same species. Presence of adult respiratory distress syndrome (83.3% versus 22.2%, p = 0.02) was the only factor significantly associated with clinical recurrences. The 16 isolates from five patients (nine recurrences) were analyzed by PFGE. All new isolates from recurrent episodes, excepting one, were considered as relapses. These data suggest that most recurrent episodes of P. aeruginosa pneumonia in ventilated patients occur due to persistence of strains present in a prior infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517611     DOI: 10.1164/ajrccm.157.3.9703014

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Optimal use of antibiotics for intubation-associated pneumonia.

Authors:  J Rello; E Diaz
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

2.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 3.  Duration of antibiotic therapy in the intensive care unit.

Authors:  Gabor Zilahi; Mary Aisling McMahon; Pedro Povoa; Ignacio Martin-Loeches
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).

Authors:  John D Williams; Matthew C Torhan; Venugopal R Neelagiri; Carson Brown; Nicholas O Bowlin; Ming Di; Courtney T McCarthy; Daniel Aiello; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

Review 5.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

6.  Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.

Authors:  Qin Lu; Cassio Girardi; Mao Zhang; Belaïd Bouhemad; Kamel Louchahi; Olivier Petitjean; Frédéric Wallet; Marie-Helene Becquemin; Gilles Le Naour; Charles-Hugo Marquette; Jean-Jacques Rouby
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

7.  Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.

Authors:  Anita Reinhardt; Thilo Köhler; Paul Wood; Peter Rohner; Jean-Luc Dumas; Bara Ricou; Christian van Delden
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

8.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

9.  Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.

Authors:  Fabio Ferrari; Qin Lu; Cassio Girardi; Olivier Petitjean; Charles-Hugo Marquette; Frederic Wallet; Jean-Jacques Rouby
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

10.  Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

Authors:  Ali A El Solh; Morohunfolu E Akinnusi; Jeanine P Wiener-Kronish; Susan V Lynch; Lilibeth A Pineda; Kristie Szarpa
Journal:  Am J Respir Crit Care Med       Date:  2008-05-08       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.